BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3908685)

  • 1. Cytokine production in inflammatory bowel disease.
    Miura M; Hiwatashi N
    J Clin Lab Immunol; 1985 Oct; 18(2):81-6. PubMed ID: 3908685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
    Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
    Danis VA; Heatley RV
    Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis.
    Kirman I; Nielsen OH
    Am J Gastroenterol; 1996 Sep; 91(9):1789-94. PubMed ID: 8792700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic response and interleukin 2 production in Crohn's disease.
    Miura M; Hiwatashi N
    J Clin Lab Immunol; 1987 Nov; 24(3):113-6. PubMed ID: 3501474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
    Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
    J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
    Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
    Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An increased number of CD40-high monocytes in patients with Crohn's disease.
    Sawada-Hase N; Kiyohara T; Miyagawa J; Ueyama H; Nishibayashi H; Murayama Y; Kashihara T; Nakahara M; Miyazaki Y; Kanayama S; Nezu R; Shinomura Y; Matsuzawa Y
    Am J Gastroenterol; 2000 Jun; 95(6):1516-23. PubMed ID: 10894589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel.
    Rachmilewitz D; Ligumsky M; Haimovitz A; Treves AJ
    Gastroenterology; 1982 Apr; 82(4):673-9. PubMed ID: 6949849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine production in patients with inflammatory bowel disease.
    Nakamura M; Saito H; Kasanuki J; Tamura Y; Yoshida S
    Gut; 1992 Jul; 33(7):933-7. PubMed ID: 1644332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 T-helper cell predominance in granulomas of Crohn's disease.
    Kakazu T; Hara J; Matsumoto T; Nakamura S; Oshitani N; Arakawa T; Kitano A; Nakatani K; Kinjo F; Kuroki T
    Am J Gastroenterol; 1999 Aug; 94(8):2149-55. PubMed ID: 10445542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.
    Fiocchi C; Hilfiker ML; Youngman KR; Doerder NC; Finke JH
    Gastroenterology; 1984 Apr; 86(4):734-42. PubMed ID: 6607860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Thurmond RD
    Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease.
    Agnholt J; Kaltoft K
    Cytokine; 2001 Aug; 15(4):212-22. PubMed ID: 11563881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
    Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
    J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
    Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S
    Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.